Efficacy and Safety of Losartan in Patients with Proteinuria

Publisher： Karger

E-ISSN： 2235-3186|91|3|496-498

ISSN： 1660-8151

Source： Nephron, Vol.91, Iss.3, 2002-07, pp. : 496-498

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Control of Severe Proteinuria with Losartan after Renal Transplantation

By  

American Journal of Nephrology, Vol. 18, Iss. 3, 1998-05 ,pp. : 261-262

Karger

Access to resources Recommend Favorite

Efficacy and Safety of Low-Dose Chlorambucil in Nephrotic Patients with Idiopathic Membranous Nephropathy

By  

Kidney and Blood Pressure Research, Vol. 32, Iss. 4, 2009-09 ,pp. : 263-267

Karger

Access to resources Recommend Favorite

Proteinuria in Diabetic Patients – Is It Always Diabetic Nephropathy?

By  

Kidney and Blood Pressure Research, Vol. 29, Iss. 1, 2006-06 ,pp. : 48-53

Karger

Access to resources Recommend Favorite

Renoprotection Provided by Losartan in Combination with Pioglitazone Is Superior to Renoprotection Provided by Losartan Alone in Patients with Type 2 Diabetic Nephropathy

By  

Kidney and Blood Pressure Research, Vol. 30, Iss. 4, 2007-06 ,pp. : 203-211

Karger

Access to resources Recommend Favorite

Renoprotective Effect of Small Doses of Losartan and Enalapril in Patients with Primary Glomerulonephritis

By  

American Journal of Nephrology, Vol. 22, Iss. 4, 2002-08 ,pp. : 356-362

Karger

Access to resources Recommend Favorite